Published: Apr, 2018
With a large pool of players operating domestically and a smaller bunch of international participants – the global platelet-rich plasma (PRP) market demonstrates a considerably fragmented landscape. That being said, this Transparency Market Research (TMR) report has identified Harvest Technologies, Arthrex Inc., Zimmer Biomet, DePuy Synthes, and Stryker Corp. as some of the companies who were ahead of the curve as of 2017. Most of these companies are headquartered in North America. However, their focus is likely to shift towards emerging economies across Asia Pacific in the coming years, as this region is expected to offer lucrative opportunities on account of untapped potential.
As per the research study, the global market for PRP, which was valued at US$195.2 million in 2017, is likely to expand at a CAGR of 12.7% during the period from 2017 to 2024 and report an opportunity worth US$451.9 mn by the end of the forecast period. The P-PRP segment, which occupied more than 60% of the overall market in 2017, is expected to remain leading throughout the forecast period.
Wide Presence of Leading Players to Ensure North America’s Dominance
The research report has also evaluated the global market for PRP on the basis of its geographical spread. It has identified North America, Asia Pacific, Europe, the Middle East and Africa, and Latin America as the key regional markets for PRP across the world. Supported by the increasing count of orthopedic and cosmetic surgeries, North America led the global market with a majority share in 2017. Further, the wide presence of leading market players and the high awareness level among consumers about PRP therapy and devices are likely to ensure the leadership of this regional market throughout the forecast period.
Asia Pacific is also expected to witness a healthy rise in the adoption of PRP therapies in the near future. The swiftly growing medical tourism industry, presence of well-established local players, increased base of the geriatric population, and the rising awareness regarding PRP among people are projected to boost the Asia Pacific PRP market over the forthcoming years, states the research report.
Increasing Count of Orthopedic Patients to Fuel Demand
“The significant increase in the count of orthopedic patients, worldwide, is the prime factor behind the tremendous progress of the global PRP market,” says a TMR analyst. As PRP therapy curtails the healing time of orthopedic or sports injuries from 4-6 months to 3-5 weeks with surgery, its demand for the treatment of orthopedic surgeries has increased remarkably and this is likely to remain so over the next few years.
The rise in cosmetic surgical procedures is another important factor that is likely to shape the future of the global PRP market. The high cost of PRP products and therapy is expected to hamper the growth of this market to some extent during the forecast period, notes the research study.
- The demand in the global PRP market is projected to expand at a CAGR of 12.7% during 2017-2024
- Emerging economies of Asia Pacific are opening vast new opportunities for the major companies who had been limited only to North America and Europe until now
The information presented in this review is based on a Transparency Market Research report, titled, “.”
Key Segments of the Global Platelet-rich Plasma Market
- Pure-Platelet Rich Plasma (P-PRP)
- Leukocyte-Platelet Rich Plasma (L-PRP)
- Pure-Platelet Rich Fibrin (P-PRF)
- Orthopedic Surgery
- Cosmetic Surgery
- General Surgery
- Other Surgeries (Urological, Cardiothoracic, Periodontal and Oral and Maxillofacial)
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453